[1]
Key, A., Pederson, A., Sant, J. and Ray, C. 2024. Teprotumumab-associated hearing-related adverse events. The Southwest Respiratory and Critical Care Chronicles. 12, 50 (Jan. 2024), 24-29. DOI:https://doi.org/10.12746/swrccc.v12i50.1261.